|
|
Rates of HSV-1 and HSV-2 vary enormously across Europe
(17 April 2003)
Data
from general populations which confirm that HSV-2 infection is a world-wide
issue are now available for many countries across Europe including Denmark,
Finland, France, Germany, Greenland, Italy, Norway, Spain, Sweden, Switzerland
and the UK. HSV-2 is the virus that commonly causes genital herpes. The
highest rates are found in Greenland, at 57% among 20-24 year olds, rising
to 74% in those aged 25-39 years. In Spain, the rates are comparatively
low, ranging from 2-6%. Scandinavia shows a prevalence of 15-35% among
women aged 25-34 years. In the UK, the highest rates reported are amongst
females in London, up to 25% in those aged 41-45 years. While interesting,
this data has sparked some expert debate as it conflicts with existing
estimates and needs further investigation.
In
the US, the overall rate for females within the general population is
26%, compared with 18% for men. Rates increase with age from mid-teens
to 35 years.
Rates
of HSV-1 are generally higher. HSV-1 is the most common type of herpes
simplex virus and usually causes facial herpes. In Germany HSV-1 is found
in up to 49% of those aged 6 to 16 years. Young women (15-25 years) in
Finland, Germany, Italy and Spain have rates ranging from 46-85%. In the
US, young women aged 18-24 years have reported rates of between 34-71%,
whereas children in New Mexico in the US have a higher rate at 79% in
the 6-15 year age bracket.
These
figures offer an insight into the trends of infection worldwide and show
that age-specific rates of HSV-2 is generally higher in women.
Further
studies are required to establish rates of infection in many other countries
and regions, particularly looking at specific age groups such as adolescents.
As more information about the epidemiological spread of herpes becomes
available, more effective control methods can be put into place to help
limit the impact of infection on populations.
Ref:
Smith JS, Hopkins J, Robinson NJ. Seroprevalence of HSV-2 and HSV-1 Infections
in the United States and Europe. Abstract presented at Eurogin April 2003.
|